The Patent Finder

Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same

Celgene Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/303,618, filed Feb 11, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,309,219Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · High confidence
UsedRemaining
Celgene CorporationIn forceHigh confidence
US 9,828,361Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · High confidence
Celgene CorporationIn forceHigh confidence
US 10,189,814Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · Medium confidence
Celgene CorporationIn forceMedium confidence
US 10,669,257Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · High confidence
Celgene CorporationIn forceHigh confidence
US 9,822,094Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · Medium confidence
Celgene CorporationIn forceMedium confidence
US 11,414,399Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · High confidence
Celgene CorporationIn forceHigh confidence
US 8,518,972Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
In force
 · High confidence
Celgene CorporationIn forceHigh confidence
Application 17/867,294Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
Pending
Not granted
Celgene CorporationPendingNot granted
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Celgene Corporation.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited